DnaJ heat shock protein family (Hsp40) member A1 pseudogene 4 (DNAJA1P4)

DNAJA1P4, or DnaJ heat shock protein family (Hsp40) member A1 pseudogene 4, is a pseudogene that resembles the functional DnaJ heat shock protein family member A1 gene but contains disabling mutations such as frameshifts or premature stop codons[1][3][4]. As a result, DNAJA1P4 does not encode a functional protein and is generally considered a non-functional genetic element[1][3][4]. Pseudogenes like DNAJA1P4 are sometimes transcribed, but there is no evidence that this specific pseudogene has a biological or clinical function[3][2]. In certain cases, some pseudogenes may act in gene regulation (for instance, as competing endogenous RNAs), but this has not been described for DNAJA1P4[2][4]. The DNAJA1P4 gene is located on chromosome 6 (114,349,483-114,350,648, reverse strand)[1][3]. There are no known drugs or mechanisms of action targeting this pseudogene, and it is not considered a therapeutic target. There are also no described safety concerns, biomarker applications, or established disease roles for this genetic locus. Based on available information, DNAJA1P4 is not a functional target and should not be classified alongside receptors, enzymes, transporters, or other canonical molecular targets in pharmacology or biomedical research[1][3][4].

Other names

DnaJ (Hsp40) homolog, subfamily A, member 1 pseudogene 4DNAJA1P4

Not applicable (not a drug target)